PMID- 27510585 OWN - NLM STAT- MEDLINE DCOM- 20170718 LR - 20181113 IS - 1476-3524 (Electronic) IS - 1029-8428 (Linking) VI - 30 IP - 4 DP - 2016 Nov TI - Characterization of the Kynurenine Pathway in CD8(+) Human Primary Monocyte-Derived Dendritic Cells. PG - 620-632 AB - The kynurenine (KYN) pathway (KP) is a major degradative pathway of the amino acid, L-tryptophan (TRP), that ultimately leads to the anabolism of the essential pyridine nucleotide, nicotinamide adenine dinucleotide. TRP catabolism results in the production of several important metabolites, including the major immune tolerance-inducing metabolite KYN, and the neurotoxin and excitotoxin quinolinic acid. Dendritic cells (DCs) have been shown to mediate immunoregulatory roles that mediated by TRP catabolism. However, characterization of the KP in human DCs has so far only been partly delineated. It is critical to understand which KP enzymes are expressed and which KP metabolites are produced to be able to understand their regulatory effects on the immune response. In this study, we characterized the KP in human monocyte-derived DCs (MDDCs) in comparison with the human primary macrophages using RT-PCR, high-pressure gas chromatography, mass spectrometry, and immunocytochemistry. Our results show that the KP is entirely expressed in human MDDC. Following activation of the KP using interferon gamma, MDDCs can mediate apoptosis of T (h) cells in vitro. Understanding the molecular mechanisms regulating KP metabolism in MDDCs may provide renewed insight for the development of novel therapeutics aimed at modulating immunological effects and peripheral tolerance. FAU - Braidy, Nady AU - Braidy N AD - Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia. n.braidy@unsw.edu.au. FAU - Rossez, Helene AU - Rossez H AD - St Vincent's Centre for Applied Medical Research, Sydney, Australia. FAU - Lim, Chai K AU - Lim CK AD - Neuropharmacology Group, MND and Neurodegenerative Diseases Research Centre, Macquarie University, Sydney, NSW, 2109, Australia. FAU - Jugder, Bat-Erdene AU - Jugder BE AD - School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia. FAU - Brew, Bruce J AU - Brew BJ AD - St Vincent's Centre for Applied Medical Research, Sydney, Australia. AD - Department of Neurology and HIV Medicine, St Vincent's Hospital, Sydney, Australia. FAU - Guillemin, Gilles J AU - Guillemin GJ AD - Neuropharmacology Group, MND and Neurodegenerative Diseases Research Centre, Macquarie University, Sydney, NSW, 2109, Australia. gilles.guillemin@mq.edu.au. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160810 PL - United States TA - Neurotox Res JT - Neurotoxicity research JID - 100929017 RN - 0 (CD8 Antigens) RN - 0 (Immunologic Factors) RN - 0 (RNA, Messenger) RN - 343-65-7 (Kynurenine) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - CD4-Positive T-Lymphocytes/cytology/drug effects/enzymology MH - CD8 Antigens/analysis MH - Cell Survival/drug effects MH - Cells, Cultured MH - Chromatography, Gas MH - Chromatography, High Pressure Liquid MH - Dendritic Cells/cytology/drug effects/*enzymology MH - Flow Cytometry MH - Humans MH - Immunohistochemistry MH - Immunologic Factors/*pharmacology MH - Interferon-gamma/*pharmacology MH - Kynurenine/antagonists & inhibitors/*metabolism MH - Macrophages/cytology/drug effects/enzymology MH - Mass Spectrometry MH - Polymerase Chain Reaction MH - RNA, Messenger/metabolism OTO - NOTNLM OT - Human monocyte-derived dendritic cells OT - Indoleamine 2,3 dioxygenase OT - Kynurenine pathway OT - Quinolinic acid EDAT- 2016/08/12 06:00 MHDA- 2017/07/19 06:00 CRDT- 2016/08/12 06:00 PHST- 2016/04/04 00:00 [received] PHST- 2016/07/29 00:00 [accepted] PHST- 2016/07/06 00:00 [revised] PHST- 2016/08/12 06:00 [pubmed] PHST- 2017/07/19 06:00 [medline] PHST- 2016/08/12 06:00 [entrez] AID - 10.1007/s12640-016-9657-x [pii] AID - 10.1007/s12640-016-9657-x [doi] PST - ppublish SO - Neurotox Res. 2016 Nov;30(4):620-632. doi: 10.1007/s12640-016-9657-x. Epub 2016 Aug 10.